SM
Summit Therapeutics
SMMT · NASDAQ
$16.90 -3.68% (-$0.65)
1M +32.76%
Market Cap $13.5B
P/E Ratio -
Div. Yield -
ROE 204.33%
Bulios Fair Price
$14.42
14.7% downside
Trenutna cena
$16.9
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SMMT trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 21.40x
PEG N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 67.93%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 204.33%
ROA 113.81%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 6.96x
Debt/Equity 0.03x
Net debt/EBITDA N/A
Stability
19 /100
Unstable EPS volatility 275.36%
Profitable years 0
Beta -1.24x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SMMT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert W. Duggan
Employees
265
Headquarters
Miami
Prihajajoči dogodki
19 OKT.
Earnings
Upcoming earnings report